Status:
UNKNOWN
The Effect of a Dietary Supplement Rich in Nitric Oxide in Patients Diagnosed With Primary Ciliary Dyskinesia.
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Primary Ciliary Dyskinesia
Eligibility:
All Genders
4-99 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the effect of a dietary supplement rich in nitric oxide (NO) on nasal nitric oxide and fractional exhaled nitric oxide (FeNO),on ciliary beat frequency assess...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Experimental group:
- PCD patients
- Control Group:
- patients with no known chronic lung disease
- 18 years to 99 years
- Exclusion Criteria(both PCD patients and control group):
- any other pulmonary co-morbidities and diseases entities like cystic fibrosis, nasal sinus surgery, nasal sinus hypoplasia/aplasia, deviated nasal septum, nasal polyps and with upper respiratory tract infection
- patients allergic to beet
- a known prolonged bleeding disorder.
Exclusion
Key Trial Info
Start Date :
July 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04489472
Start Date
July 31 2019
End Date
May 1 2024
Last Update
May 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030